MedPath

Functional MRI to Assess Brain Damage in Cardiac Arrest Patients

Completed
Conditions
Cardiac Arrest
Brain Injuries
Registration Number
NCT05966389
Lead Sponsor
Capital Medical University
Brief Summary

This is a single-center, observational study. Patients after successful cardiopulmonary resuscitation (CPR) will be transferred to the emergency intensive care unit for further standardized management. After successful return of spontaneous circulation (ROSC) for 72h and hemodynamics remained stable for 24h, the post-resuscitated patients underwent functional magnetic resonance imaging (fMRI) examination. During the examination, the supervising physician accompanied the patient and monitored the patient's vital signs using a magnetic resonance monitoring system (Siemens Healthcare Prism, Germany). Patients who are on ventilators are mechanically ventilated using a magnetic ventilator (HAMILTON-MRI, USA). In additional to conventional sequences, fMRI is performed for diffusion-prepared pseudo-continuous arterial spin labeling (DP-pCASL) and blood oxygenation level dependent functional magnetic resonance imaging (BOLD-fMRI). These MRI sequences allow quantitative assessment of the patients' cerebral microcirculation, blood-brain barrier, and cerebral oxygenation status. Patients will be followed up for neurologic prognosis according to the Modified Rankin Scale (mRS) at 6 months after disease onset.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • age ≥18 years.
  • sustained hemodynamic stability for ≥24h.
  • the patients were unconscious and not able to obey verbal commands.
  • Advanced life support and target temperature management within 6 hours of return of spontaneous circulation (ROSC).
Exclusion Criteria
  • Patients with hemodynamic instability.
  • Patients who could not complete cranial MRI examination for special reasons.
  • Patients during pregnancy.
  • Patients who combined traumatic brain injury, stroke, cerebral hemorrhage and other diseases.
  • Patients whose family members did not agree to be enrolled.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Neurologic prognosis6 months

Patients will be followed up for neurologic prognosis according to the Modified Rankin Scale (mRS) at 6 months after disease onset.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beijing chaoyang hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath